Drug recall · November 5, 2014
Emtriva recall
Why: Defective Container; leaking around the cap
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Emtriva (emtricitabine) Oral Solution, 10 mg/mL, 170 mL bottles, Rx only, Manufactured for Gilead Sciences, Inc., Foster City, CA NDC 61958-0602-1 Gilead Sciences, Inc. Foster City, CA 94404.
- Lots / codes
FG Lot Number: HDNTD1 and HDNTD exp 30-Jun-15, KCMGD and KCMGD1 exp 31-Oct-15, KYGHA, KYGKA and KYGKK exp 30-Apr-16, MZVBA and MZTZA exp 31-Oct-16
- Quantity
- 6,290 bottles
- Company
- Gilead Sciences, Inc., Foster City, CA
- Distribution
- United States, Puerto Rico, Fiji.
- Initiated
- October 1, 2014 · Voluntary: Firm initiated
- Classified
- October 24, 2014
- Reported
- November 5, 2014
- Ended
- May 11, 2015
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Emtricitabine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.